759P Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer
| Autor: | Polyakov, S., Krasny, S., Zhavrid, E., Baranau, Y., Sergeeva, O., Zharkova, K., Khorau, A., Kozlovskaya, S., Gabai, V., Shneider, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S747-S748 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|